மாப் News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from மாப். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In மாப் Today - Breaking & Trending Today
Al Maha Academy for Boys (AMAB) has received a positive visit from Undersecretary of the Ministry of Education and Higher Education, Dr. Ibrahim Al Nuaimi. ....
NEW YORK CITY (dpa-AFX) - Biopharmaceutical company Xencor, Inc. (XNCR) announced Tuesday it has entered into a technology license agreement with Bristol-Myers Squibb Co. (BMY) under which Bristol ....
How to Know If You re Maximizing Your mAb Recovery High concentration mAb formulations and their properties Image credit: Pall Corporation Having first emerged as therapeutics in the 1980s, monoclonal antibodies (mAbs) are the predominant class of recombinant biologic drugs in development. While intravenous (IV) infusion is a frequently utilized administration route for mAbs, for patients requiring a frequent dosing regimen, subcutaneous delivery (sub-C) in doses between 1-1.5 mL is now preferred as it supplies the possibility of self-treatment by utilizing pre-filled syringes 2. mAbs are usually required to be prepared at concentrations that are higher than 100 g/L and up to 250 g/L ....
Vir Biotechnology and GSK Announce VIR-7831 Reduces Hospitalization and Risk of Death in Early Treatment of Adults with COVID-19 March 10, 2021 20:22 ET | Source: Vir Biotechnology, Inc. Vir Biotechnology, Inc. San Francisco, California, UNITED STATES – Independent Data Monitoring Committee recommends stopping Phase 3 COMET-ICE trial early given an 85% reduction in hospitalization or death – – Vir and GSK plan to immediately seek Emergency Use Authorization in the U.S. and authorizations in other countries – – Additional new in vitro studies indicate VIR-7831 maintains activity against major circulating COVID-19 variants – SAN FRANCISCO and LONDON, March 10, 2021 (GLOBE NEWSWIRE) Vir Biotechnology, Inc. (Nasdaq: VIR) and GlaxoSmithKline plc (LSE/NYSE: GSK) today announced that an Independent Data Monitoring Committee (IDMC) recommended that the Phase 3 COMET-ICE (COVID-19 Monoclonal ....
22 February 2021 | 07:08am StockMarketWire.com - Pub group Mitchells & Butlers, while launching a planned £350 million equity raising, said its sales had fallen sharply due to the UK s Covid-19 lockdown. Managed sales between 27 September and 16 January had dropped 70% year-on-year, the company said. On a like-for-like basis for sites when open, excluding periods of closure trading was down 30%. Mitchells & Butlers said none of its sites had been open since the government announced fresh lockdown measures on 30 December. The company had a cash balance of £113 million at 16 January with all facilities drawn. Monthly pension contributions from January to March, inclusive, would be delayed, with these becoming due in April. ....